NXP stock price slips 1.8% — JPMorgan’s 8% stake filing sets up a busy week for NXPI
25 January 2026
1 min read

NXP stock price slips 1.8% — JPMorgan’s 8% stake filing sets up a busy week for NXPI

New York, January 24, 2026, 19:35 EST — Market closed

  • NXP shares dropped 1.81% Friday, closing at $232.48 and snapping a two-day rally.
  • A regulatory filing showed JPMorgan Chase & Co owned 8.0% of NXP shares as of Dec. 31.
  • Traders are focused on the Fed’s rate decision coming up on Jan. 28, with NXP’s earnings report due after the close on Feb. 2 also in the spotlight.

NXP Semiconductors’ shares fell 1.81% on Friday in the U.S., closing at $232.48 and lagging behind rivals during a mixed day on Wall Street. The stock finished the week about 9% below its 52-week high, with trading volume edging above recent levels. 1

The pullback arrives as investors pivot from this month’s geopolitical noise back to earnings and interest rates. “At the end of the day, earnings are the driver,” said Chris Galipeau, senior market strategist at Franklin Templeton, highlighting a busy week ahead with earnings reports and a Federal Reserve decision. 2

NXP is set to release its fourth-quarter and full-year 2025 earnings after markets close on Monday, Feb. 2. A conference call will follow the next morning. 3

Investors received fresh data before the week started. An amended Schedule 13G showed JPMorgan Chase & Co owns 20,347,898 shares of NXP, equating to 8.0% of the company’s class as of Dec. 31. 4

Semiconductor stocks hit headwinds on Friday, barely budging alongside the broader market. Intel’s shares plunged sharply after the company flagged supply shortages, highlighting that even with growing AI infrastructure demand, chipmakers still face serious capacity and execution hurdles. 5

NXP’s stock experienced swings on Friday, moving between $229.12 and $238.61. About 3.26 million shares changed hands during the session.

NXP lagged behind its peers in the analog and mixed-signal sector. Qualcomm, Texas Instruments, and Analog Devices all finished lower, reflecting the cautious tone among leading chip stocks as the weekend approached.

The bigger macro test comes first. On Wednesday, Jan. 28, the Federal Reserve will unveil its policy decision. Traders are eager to gauge how long officials plan to maintain the current rates — a key detail for high-multiple tech and semiconductor stocks.

Next week, a wave of earnings reports from U.S. mega-cap tech giants hits, spotlighting data center and AI infrastructure spending. Any slip-up could rattle chip stocks, especially those like NXP, which lean heavily on automotive and industrial markets.

The risk cuts both ways for NXP investors. If the Fed turns more cautious than expected or appetite for risk cools off, chip stocks could take a sharp hit. On top of that, NXP’s next earnings report might disappoint if customers slow their inventory buildup and order flow.

NXPI is set to release its earnings after the market closes on Feb. 2. The following day, Feb. 3, the company will host a conference call. Investors will zero in on demand patterns, margin shifts, and the pace of shareholder returns during the discussion.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
TE Connectivity stock drops 3% into weekend as banks lift targets — what to watch next (TEL)
Previous Story

TE Connectivity stock drops 3% into weekend as banks lift targets — what to watch next (TEL)

Infineon stock heads into Monday after fresh target hikes — earnings next
Next Story

Infineon stock heads into Monday after fresh target hikes — earnings next

Go toTop